Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release morphine during pulmonary rehabilitation for COPD
ACTRN12615000121561Phase 3Terminated
- Sponsor
- Flinders University
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of morphine hydrochloride and docusate sodium + senna in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Flinders University. Started May 2015; status: terminated.
02
Drugs
morphine hydrochloridedocusate sodium + senna
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12615000121561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000121561.